Cary Street Partners Investment Advisory LLC Purchases New Shares in iShares Biotechnology ETF $IBB

Cary Street Partners Investment Advisory LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 5,915 shares of the financial services provider’s stock, valued at approximately $998,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of IBB. Brighton Jones LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at $201,000. AQR Capital Management LLC purchased a new position in iShares Biotechnology ETF during the 1st quarter worth $455,000. Millennium Management LLC raised its position in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after buying an additional 143,893 shares during the last quarter. M&T Bank Corp raised its position in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after buying an additional 750 shares during the last quarter. Finally, Walleye Capital LLC raised its position in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after buying an additional 985 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $168.79 on Tuesday. iShares Biotechnology ETF has a one year low of $119.78 and a one year high of $179.64. The firm has a fifty day moving average of $168.95 and a two-hundred day moving average of $170.07.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.